INAB (STOCKS)
IN8bio, Inc. Common Stock
$1.350000
-0.040000 (-2.88%)
Prev close: $1.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William T. Ho
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.39M
- Employees
- 18
- P/E (TTM)
- -0.29
- P/B (TTM)
- 0.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.45 | $-0.63 | +0.1790 | +28.46% |
|
Sep 2025 (Q3)
|
$-0.85 | $-1.25 | +0.4046 | +32.25% |
|
Jun 2025 (Q2)
|
$-1.24 | $-1.84 | +0.5960 | +32.46% |
|
Mar 2025 (Q1)
|
$-2.10 | $-2.04 | -0.0599 | -2.94% |
Financial Statements
| Revenues | $421.00K |
| Benefits Costs and Expenses | $19.86M |
| Costs And Expenses | $19.86M |
| Operating Expenses | $19.86M |
| Research and Development | $10.21M |
| Other Operating Expenses | $9.65M |
| Operating Income/Loss | -$19.44M |
| Income/Loss From Continuing Operations After Tax | -$17.02M |
| Income/Loss From Continuing Operations Before Tax | -$19.44M |
| Income Tax Expense/Benefit | -$2.42M |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | -$2.42M |
| Net Income/Loss | -$19.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.44 |
| Diluted Earnings Per Share | -$4.44 |
| Basic Average Shares | 4,374,328 |
| Diluted Average Shares | 4,374,328 |
| Assets | $32.28M |
| Current Assets | $27.88M |
| Noncurrent Assets | $4.40M |
| Fixed Assets | $1.86M |
| Other Non-current Assets | $2.54M |
| Liabilities | $4.72M |
| Current Liabilities | $3.16M |
| Accounts Payable | $309.00K |
| Other Current Liabilities | $2.85M |
| Noncurrent Liabilities | $1.56M |
| Equity | $27.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.56M |
| Liabilities And Equity | $32.28M |
| Net Cash Flow From Operating Activities | -$12.71M |
| Net Cash Flow From Operating Activities, Continuing | -$12.71M |
| Net Cash Flow From Investing Activities | -$15.93M |
| Net Cash Flow From Investing Activities, Continuing | -$15.93M |
| Net Cash Flow From Financing Activities | $28.64M |
| Net Cash Flow From Financing Activities, Continuing | $28.64M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$19.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.44M |
| Other Comprehensive Income/Loss | $0.00 |